Anteris Technologies Global Corp. AVR 深 滬
已收盤 08-01 16:00:00 美东时间
3.07
-0.140
-4.36%
華盛通- 最 高3.29
- 今 開3.15
- 成交量 8.61万股
- 最 低 2.9901
- 昨 收 3.21
- 總市值 1.11亿
- 52周最高 8.79
- 市盈率 靜 --
- 換手率 0.24%
- 52周最低 2.34
- 委 比 51.72%
- 總股本 3606.21万
- 歷史最高 8.79
- 量 比 0.44
- 振 幅 9.34%
- 歷史最低 2.34
- 每 手 1
- 風險率
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多山东省青岛市市场监督管理局公布40批次玩具产品监督抽查结果
中国质量新闻网讯 近日，山东省青岛市市场监督管理局公布2025年第一批工业产品质量日常监督抽查结果。其中，抽查40批次玩具产品，生产领域16批次，流通领域24批...
07-11 15:31
Anteris Technologies Updates CDI Issuance for June 2025
Anteris Technologies ( ($AU:AVR) ) just unveiled an announcement. Anteris Techn...
07-03 15:27
Anteris Technologies Strengthens Board with Key Appointments
Anteris Technologies ( ($AU:AVR) ) has shared an update. Anteris Technologies G...
06-10 08:08
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
Anteris Technologies Global Corp. has appointed David Roberts and Gregory Moss to its Board of Directors, bringing extensive experience in healthcare, legal, and corporate leadership. This move follows the company's NASDAQ listing and upcoming global pivotal trial for its DurAVR® THV, aimed at treating aortic stenosis. Both executives will play key roles in guiding the company through its next phase of growth.
06-10 02:52
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers SCWorx (NASDAQ:WORX) shares rose 60.0% to $0.64 during Tuesday's regul...
05-28 01:05
Anteris Technologies Issues New Employee Incentive Securities
An announcement from Anteris Technologies ( ($AU:AVR) ) is now available. Anter...
05-16 16:07
Anteris Technologies Files Amendment to Annual Report
Anteris Technologies ( ($AU:AVR) ) has issued an announcement. Anteris Technolo...
04-30 09:57
Anteris Technologies Appoints New President to Strengthen Leadership
Anteris Technologies ( ($AU:AVR) ) has issued an update. Anteris Technologies G...
03-06 15:29
美股大行评级 | 潜在涨幅297%！SLDB获机构首予“买入”评级，目标价16美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1084034232603127809.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• TD Cowen：上调GeneDx目标价从75美元至118美元</p> <p>• HC Wainwright & Co.：维持Sana Biotechnology(SANA)"买入"评级，目标价从8美元升至11美元
01-09 09:31
